1.0Neurology Advisorhttps://www.neurologyadvisor.comSachihttps://www.neurologyadvisor.com/author/sachitanwar/Treatment of Early Alzheimer Disease: Key Takeaways From AAIC 2025rich600338<blockquote class="wp-embedded-content" data-secret="GOSgsDpTkJ"><a href="https://www.neurologyadvisor.com/cch/early-alzheimer-disease-aaic-2025-disease-modifying-therapy-donanemab-lecanemab/">Treatment of Early Alzheimer Disease: Key Takeaways From AAIC 2025</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.neurologyadvisor.com/cch/early-alzheimer-disease-aaic-2025-disease-modifying-therapy-donanemab-lecanemab/embed/#?secret=GOSgsDpTkJ" width="600" height="338" title="“Treatment of Early Alzheimer Disease: Key Takeaways From AAIC 2025” — Neurology Advisor" data-secret="GOSgsDpTkJ" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]> */
</script>
https://www.neurologyadvisor.com/wp-content/uploads/sites/10/2025/08/CCH_MeetingInsights_TextOnly_FINAL-7.png23571333The Alzheimer's Association International Conference (AAIC) 2025 presented the latest research on Alzheimer disease (AD) and dementia, including updates on clinical trials, preclinical drug development, and clinical management. In this article, Samuel E. Gandy, MD, PhD, provides his perspective on research presented at AAIC 2025 on treatment strategies for early symptomatic AD.